ArticleCancer immunology, immunotherapy : CII2016

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.

Kalijn F Bol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.